Bio-Techne

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Bio-Techne and other ETFs, options, and stocks.

About TECH

Bio-Techne Corp. is a global life sciences company providing innovative tools and bioactive reagents for research and clinical diagnostic communities. Its products assist scientific investigations into biological processes and the nature and progress of specific diseases. 

CEO
Kim Kelderman
CEOKim Kelderman
Employees
3,100
Employees3,100
Headquarters
Minneapolis, Minnesota
HeadquartersMinneapolis, Minnesota
Founded
1976
Founded1976
Employees
3,100
Employees3,100

TECH Key Statistics

Market cap
11.16B
Market cap11.16B
Price-Earnings ratio
102.41
Price-Earnings ratio102.41
Dividend yield
0.45%
Dividend yield0.45%
Average volume
8.89M
Average volume8.89M
High today
$71.39
High today$71.39
Low today
$70.84
Low today$70.84
Open price
$71.08
Open price$71.08
Volume
2.35M
Volume2.35M
52 Week high
$72.16
52 Week high$72.16
52 Week low
$43.20
52 Week low$43.20

Stock Snapshot

With a market cap of 11.16B, Bio-Techne(TECH) trades at $71.30. The stock has a price-to-earnings ratio of 102.41 and currently yields dividends of 0.45%.

On 2026-07-11, Bio-Techne(TECH) stock traded between a low of $70.84 and a high of $71.39. Shares are currently priced at $71.30, which is +0.6% above the low and -0.1% below the high.

Bio-Techne(TECH) shares are trading with a volume of 2.35M, against a daily average of 8.89M.

In the last year, Bio-Techne(TECH) shares hit a 52-week high of $72.16 and a 52-week low of $43.20.

In the last year, Bio-Techne(TECH) shares hit a 52-week high of $72.16 and a 52-week low of $43.20.

TECH News

TipRanks 2d
Bio-Techne downgraded to Sector Perform from Outperform at RBC Capital

RBC Capital analyst Dan Leonard downgraded Bio-Techne (TECH) to Sector Perform from Outperform with a price target of $73, up from $62, citing the view that Mer...

Investing.com 3d
RBC Capital downgrades Bio-Techne stock rating on acquisition view - Investing.com

...

RBC Capital downgrades Bio-Techne stock rating on acquisition view - Investing.com

Analyst ratings

83%

of 18 ratings
Buy
16.7%
Hold
83.3%
Sell
0%

People also own

Based on the portfolios of people who own TECH. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.